1. The trimethoxyphenyl (TMP) functional group: a versatile pharmacophore
   Mohammad Amin Langarizadeh et al, 2023, Medicinal Chemistry Research CrossRef
2. Recent Advances in β-lactam Derivatives as Potential Anticancer Agents
   Xinfen Zhang et al, 2020, Current Topics in Medicinal Chemistry CrossRef
3. β-Lactam analogues of combretastatin A-4 prevent metabolic inactivation by glucuronidation in chemoresistant HT-29 colon cancer cells
   Azizah M. Malebari et al, 2017, European Journal of Medicinal Chemistry CrossRef
4. Modularly Engineered Solid‐Phase Synthesis of Aptamer‐Functionalized Small Molecule Drugs for Targeted Cancer Therapy
   Dan Wang et al, 2020, Advanced Therapeutics CrossRef
5. Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro
   SEEMA-MARIA NATHWANI et al, 2013, Oncology Reports CrossRef
6. Combretazet-3 a novel synthetic cis-stable combretastatin A-4- azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer
   LISA M. GREENE et al, 2013, Oncology Reports CrossRef
7. Theoretical and experimental study of polycyclic aromatic compounds as β-tubulin inhibitors
   Fabian E. Olazarán et al, 2017, Journal of Molecular Modeling CrossRef
8. Combretastatins: More Than Just Vascular Targeting Agents?
   Lisa M. Greene et al, 2015, Journal of Pharmacology and Experimental Therapeutics CrossRef